The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages
Open accessAbstract
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial pneumonia and has one of the poorest prognosis. However, the molecular mechanisms underlying IPF progression remain largely unknown. In this study, we determined that IL-24, an IL-20 subfamily cytokine member, was increased both in the serum of IPF patients and the bronchoalveolar lavage fluid (BALF) of mice following bleomycin (BLM)-induced pulmonary fibrosis. As a result, IL-24 deficiency protected mice from BLM-induced lung injury and fibrosis. Specifically, loss of IL-24 significantly attenuated transforming growth factor β1 (TGF-β1) production and reduced M2 macrophage infiltration in the lung of BLM-induced mice. Mechanistically, IL-24 alone did not show a perceptible impact on the induction of M2 macrophages, but it synergized with IL-4 to promote M2 program in macrophages. IL-24 suppressed IL-4-induced expression of suppressor of cytokine signaling 1 (SOCS1) and SOCS3, through which it enhanced signal transducer and activator of transcription 6/peroxisome proliferator-activated receptor gamma (STAT6/PPARγ) signaling, thereby promoting IL-4-induced production of M2 macrophages. Collectively, our data support that IL-24 synergizes with IL-4 to promote macrophage M2 program contributing to the development of pulmonary fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IPF patients are predominantly infiltrated by M2 macrophages during disease progression 12, 13.”
From Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice (2024) · cites this paper as [12]
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Hashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
Richeldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
Martinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Vergadi, E., Ieronymaki, E., Lyroni, K., Vaporidi, K., & Tsatsanis, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601515 · Cited by 1,148
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
Hutchinson, J., Fogarty, A., Hubbard, R., & McKeever, T. M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00185114 · Cited by 913
Cited by
Sorted by citations
Items 101–164 of 164
Song, P., Li, P., Huang, Z., Yuan, Y., Wei, M., Wang, C., Zhang, G., Ji, M. J., & Guan, H. (2023) · Translational Vision Science & Technology · doi:10.1167/tvst.12.11.23 · Cited by 3
Self-citationThe Role of Interleukin-24 and Downstream Pathways in Inflammatory and Autoimmune Diseases
An, Q., Gu, X., & Jiang, Y. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01576-3 · Cited by 3
Resolution of innate immune cells with proresolving lipid mediators in idiopathic pulmonary fibrosis
Ang, Y., Ng, A. J. K., Liao, W., Wong, K. Y. K., Wong, W. S. F., & Peh, H. Y. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf100 · Cited by 3
Resveratrol improves idiopathic pulmonary fibrosis by targeting IKZF3
Liu, S., Wang, L., Yu, Y., Ma, D., Deng, X., Wang, Y., Wu, D., Wang, Y., & Wu, Q. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110082 · Cited by 3
Self-citationLi, J., Zhang, Q., Zhao, P., Mei, X., Shi, Y., Shao, W., & Yu, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149590 · Cited by 3
Self-citationZhao, C., Xiao, A., Chen, C., Mu, W., Li, W.-Y., & Chang, L. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102889 · Cited by 3
Yun, C.-X., Huan, M., Zhu, X., Wan, Y.-H., Zou, J., & Zhang, B. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124302 · Cited by 3
Bao, Y., Yang, S., Zhao, H., Wang, Y., Li, K., Liu, X., Zhang, W., & Zhu, X. L. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-02976-0 · Cited by 4
Self-citationElimination of docetaxel-induced senescence attenuates malignant progression in RB1-deficient CRPC
Su, H., Huang, L., Xia, W., Tang, D. G., Zhou, J., & Yang, G. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01126-w · Cited by 3
Zhang, J., Zhou, J., Wang, Y., Yang, Y., Yue, T., & Chang, C. (2025) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2025.100415 · Cited by 2
Self-citationCILP attenuates pulmonary fibrosis through the TGF-β1/SMAD3 pathway
Zou, H., Dong, J., Zhao, R., Liu, F., Cheng, J., Li, X., Fei, C., Li, P., & Liu, C. (2025) · European journal of medical research · doi:10.1186/s40001-025-03644-7 · Cited by 2
Li, C., Yuan, Y., Bao, Y., Ni, Y., Chen, N., Piao, J., Wang, L., & Zhu, Z. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04071-4 · Cited by 2
Tao, Z.-A., Li, L.-L., Wang, J., Niu, C., & Zhao, Z.-G. (2026) · Inflammation Research · doi:10.1007/s00011-026-02239-0 · Cited by 3
Goleij, P., Amini, A., Abolfazli, S., Heidari, M. M., Tabari, M. A. K., Aschner, M., Larsen, D. S., Khan, H., & Daglia, M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01975-9 · Cited by 2
Gupta, A. A., Sasse, S. K., Gruca, M. A., Sanford, L., Dowell, R. D., & Gerber, A. N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.23.432311 · Cited by 2
IL-24 in COVID-19 Patients: Correlations with Disease Progression
Vollenberg, R., Schütte‐Nütgen, K., Strauß, M., Trebicka, J., Fischer, J., & Tepasse, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178403 · Cited by 1
Zou, J., Jian, J., Ge, D., Zhou, B., & Zhang, J. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70586 · Cited by 1
Xiang, M., Yao, Z., Shao, W., Chen, M., Tang, W., Liu, D., & Zhang, J. (2025) · Advances in Wound Care · doi:10.1177/21621918251405876 · Cited by 1
Jung, W., Kim, M. S., Kim, B.-G., Hong, S.-M., Yu, S., Kwon, K., Yang, M.-J., Heo, M. B., Kwon, I. H., Choi, S.-J., et al. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117695 · Cited by 1
Rubiadin-1-methyl ether alleviates bleomycin induced pulmonary fibrosis
Zhen, X., Xinpeng, L., Sun, J., Yuhang, Z., Mengjia, Y., Yanjuan, Z., & Yongchun, C. (2026) · Scientific Reports · doi:10.1038/s41598-026-35352-5 · Cited by 1
Talmon, M., Mares, A., Balasubramanian, H. B., Mocchetti, C., Camillo, L., Balbo, P. E., Fresu, L. G., & Patrucco, F. (2026) · Biomolecules · doi:10.3390/biom16020319 · Cited by 2
Chen, C., Cui, D., Yang, S., Yuan, W., & Yang, L. (2026) · Gene · doi:10.1016/j.gene.2026.150143 · Cited by 1
Oxidized mtDNA Contributes to Pulmonary Inflammation and Fibrosis in Bleomycin‐Induced Lung Injury
Mao, Y., Tian, X., Ai, J., Zhou, X., Ni, Y., Wan, D., Luo, M., & Wei, X. (2026) · MedComm · doi:10.1002/mco2.70664 · Cited by 1
Nie, Y., Xu, L., Liu, Y., Li, J., Wang, Z., Zhai, X., Sun, X., Hu, C., Xu, B., Wu, Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71639-x · Cited by 1
Self-citationKe-gong, C., Zhang, C.-S., Ma, Y.-H., Xu, H.-Q., Jin, C.-L., Ji, L., Ning, G.-Y., Guo, X.-H., Zhang, R.-Q., Cai, P.-A., et al. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215002 · Cited by 1
Shi, L., Zhou, H., & Zheng, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1793796
Roles of Interleukin‐24 in Epithelial Repair: Bridging Injury and Regeneration
Bryant, M., Janas, P. P., & Sanchez, T. (2025) · Allergy · doi:10.1111/all.16479 · Cited by 1
Song, J., Ke, B., & Fang, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2760468/v1 · Cited by 1
Wei, Q., Li, M., Yang, Q., Ren, M., Liu, X., Cai, X., Shi, J., Huang, C., Wang, Y., Zhang, Y., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04432-z
Self-citationFunctionele biodiversiteit : micro-organismen
Bloem, J. (2009) · Socio-Environmental Systems Modeling
Wang, L., Li, B., Zhang, Z., & Yuan, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1338991/v1
Pulmonary Fibrosis: One Manifestation, Various Diseases
Ruaro, B., Matucci‐Cerinic, M., Baratella, E., Confalonieri, M., Salton, F., & Hughes, M. (2022) · Frontiers research topics · doi:10.3389/978-2-83250-654-7
Zeng, C., Wang, Q., liu, X., Wang, C., Zhou, Q., Fu, X., Yu, J., Xiong, W., Wang, Y., & Ju, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3212738/v1
Self-citationQiu, Y., Liu, C., Shi, Y., Hao, N., Tan, W., & Wang, F. (2023) · Figshare · doi:10.6084/m9.figshare.23930192
Self-citationQiu, Y., Liu, C., Shi, Y., Hao, N., Tan, W., & Wang, F. (2023) · Figshare · doi:10.6084/m9.figshare.23930195
Self-citationHuang, X., Zheng, L., Li, L., Lin, L., Liu, Z., & Zhou, C. (2024) · Applied Materials Today · doi:10.1016/j.apmt.2024.102340
Self-citationSong, J., Ke, B., & Fang, X. (2024) · BioMed Research International · doi:10.1155/2024/5674711
Luo, P., Gu, Q., Wang, J., Meng, X., & Zhao, M. (2025) · Biomedicines · doi:10.3390/biomedicines13030690
Xie, M., Diao, Y., Zhang, J., Hao, M., Wang, Z., Tan, R., Ma, J., Hu, X., Hao, Z., & Zhu, T. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578800
Bao, Y., Yang, S., Zhao, H., Wang, Y., Li, K., Liu, X., Zhang, W., & Zhu, X. L. (2024) · Figshare · doi:10.6084/m9.figshare.26705973
Self-citationBao, Y., Yang, S., Zhao, H., Wang, Y., Li, K., Liu, X., Zhang, W., & Zhu, X. L. (2024) · Figshare · doi:10.6084/m9.figshare.26705970
Self-citationBao, Y., Yang, S., Zhao, H., Wang, Y., Li, K., Liu, X., Zhang, W., & Zhu, X. L. (2024) · Figshare · doi:10.6084/m9.figshare.26705988
Self-citationBao, Y., Yang, S., Zhao, H., Wang, Y., Li, K., Liu, X., Zhang, W., & Zhu, X. L. (2024) · Figshare · doi:10.6084/m9.figshare.26705964
Self-citationBao, Y., Yang, S., Zhao, H., Wang, Y., Li, K., Liu, X., Zhang, W., & Zhu, X. L. (2024) · Figshare · doi:10.6084/m9.figshare.26705976
Self-citationChoi, S. M., Mo, Y., Bang, J.-Y., Ko, Y. G., Ahn, Y. H., Kim, H. Y., Koh, J., Yim, J.-J., & Kang, H.-R. (2024) · Figshare · doi:10.6084/m9.figshare.26572882
Bao, Y., Yang, S., Zhao, H., Wang, Y., Li, K., Liu, X., Zhang, W., & Zhu, X. L. (2024) · Figshare · doi:10.6084/m9.figshare.26705985
Self-citationFeng, K.-N., Meng, P., Zou, X., Zhang, M., Li, H.-K., Yang, H., Li, H.-T., & Zhang, T. (2022) · Figshare · doi:10.6084/m9.figshare.21099088
Bao, Y., Yang, S., Zhao, H., Wang, Y., Li, K., Liu, X., Zhang, W., & Zhu, X. L. (2024) · Figshare · doi:10.6084/m9.figshare.26705979
Self-citationBao, Y., Yang, S., Zhao, H., Wang, Y., Li, K., Liu, X., Zhang, W., & Zhu, X. L. (2024) · Figshare · doi:10.6084/m9.figshare.26705982
Self-citationQiu, Y., Liu, C., Shi, Y., Hao, N., Tan, W., & Wang, F. (2023) · Figshare · doi:10.6084/m9.figshare.23930189
Self-citationBao, Y., Yang, S., Zhao, H., Wang, Y., Li, K., Liu, X., Zhang, W., & Zhu, X. L. (2024) · Figshare · doi:10.6084/m9.figshare.26705967
Self-citationSegmentation and calculation of lung fibrosis in IPF mice by 2.5D UNet
Zheng, Y., Weng, T., Chang, Y., Ma, S., Zhang, J., & Guo, L. (2026) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ae38e5
Chen, G., Huang, C., Wang, Z., Gu, W., Jie, H., Xiong, T., Liu, Y., Feng, Y., Yi, L., Xue, Z., et al. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114953
Interleukin-24 in type 2 immune diseases
Song, X., Lan, D., & Liu, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1776623
Lu, J., Feng, X., Chang, X., Cheng, W., Pan, P., & Wu, J. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02115-5
ICOS+ T helper 2 cells promote the pulmonary fibrosis in systemic sclerosis
Zhu, H., Chen, Y. R., Wu, Y., Zhang, Y., Liu, S., You, N. Y., Liu, M., Wang, Z., Wang, D., & Sun, L. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01455-y
Hickman, E., Chou, C., Seifert, C. W., Chappel, J. R., Kim, Y. H., Corteselli, E., & Rager, J. E. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag035
Yue, H., Dong, R., He, J., Zhang, F., Fan, Y., Dou, X., Zhou, Q., Li, X. W., He, L., Zhang, S. C., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02900-5
Self-citationSun, X., Zhao, J., Ma, Y., Kong, Z., & Su, G. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.04.007
Self-citationWang, F., Bai, F., Zhou, T., Liu, H., Wu, D.-J., Zhou, Y., & Li, W. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103589
Self-citationLiu, B.-Y., Zhang, Y.-N., Zhang, G., Hua, Z.-Y., Gao, Y.-F., Niu, Y.-X., Deng, Y.-Y., Lu, Y., Li, X., & Liu, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116871
Yin, L., Huang, H., Zhu, J., & Lin, P. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116950
Ge, L., Chen, W., Han, S., Yang, H., Du, M., Li, S., Bai, X., Zhao, P., Chen, D., Pang, Q., et al. (2026) · Inflammation Research · doi:10.1007/s00011-026-02309-3
Li, J., Yang, X., & Tang, X. X. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70685
Self-citation
Metadata
- Authors
- Rao, L.-Z., Wang, Y., Zhang, L., Wu, G., Zhang, L., Wang, F.-X., Chen, L.-M., Sun, F., Jia, S., Zhang, S., Yu, Q., Wei, J.-H., Lei, H.-R., Yuan, T., Li, J., Huang, X., Cheng, B., Zhao, J., Xu, Y., Mo, B.-W., Wang, C.-Y., & Zhang, H.
- Affiliations
- Tongji Hospital (CN)
- Guilin Medical University (CN)
- Central South University (CN)
- ShanghaiTech University (CN)
- Corresponding author
- Wang, Yi
- Wang, Cong-Yi
- Zhang, Huilan
- ORCID
- Venue
- Cell Death & Differentiation
- Published
- 2020-11-03
- Volume
- 28
- Issue
- 4
- Pages
- 1270-1283
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- PMC
- PMC8027679
- OpenAlex
- W3095707317
- Cited by
- 153
- References
- 48
- Citations by year
- 2026: 24 · 2025: 37 · 2024: 39 · 2023: 21 · 2022: 22 · 2021: 9
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-01-05)
- Open access
- bronze
- doi.org
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81530024)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- IL-24, idiopathic pulmonary fibrosis, bleomycin-induced lung fibrosis, M2 macrophages, IL-4, SOCS1, SOCS3, TGF-β1, macrophage polarization, pulmonary fibrosis
- MeSH terms
- Interleukin-24, Animals, Bleomycin, Disease Models, Animal, Female, Humans, Interleukins, Macrophages, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, Signal Transduction, Interleukin-4, Mice, Knockout, Mice, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review